Navigation Links
PCASMC (P350-05) from European Collection of Cell Cultures (ECACC)

ProductsPCASMC (P350-05) from European Collection of Cell Cultures (ECACC)
Company European Collection of Cell Cultures (ECACC)
Item PCASMC (P350-05)
Price 
Description Porcine Coronary Artery Smooth Muscle Cells (PCASMC) (>500,000 cells)
Info European Collection of Cell Cultures (ECACC) European Collection of Cell Cultures (ECACC)
United Kingdom
Customer Service: +44 (0) 1980 612684
Fax Number: +44 (0) 1980 611315
Web Site: http://www.ecacc.org.uk/
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. The National Collection of Pathogenic Viruses (NCPV) from European Collection of Cell Cultures (ECACC)
2. CnC (Cn402-05) from European Collection of Cell Cultures (ECACC)
3. CAOSMC (C354-05) from European Collection of Cell Cultures (ECACC)
4. CnAOSMC (Cn354-05) from European Collection of Cell Cultures (ECACC)
5. PPAEC (P302-05) from European Collection of Cell Cultures (ECACC)
6. PPASMC (P352-05) from European Collection of Cell Cultures (ECACC)
7. HER2plus Control Slides from European Collection of Cell Cultures (ECACC)
8. BBMVEC (B840-05) from European Collection of Cell Cultures (ECACC)
9. BAOSMC (B354-05) from European Collection of Cell Cultures (ECACC)
10. BPAEC (B302-05) from European Collection of Cell Cultures (ECACC)
11. BRAEC (B900-05) from European Collection of Cell Cultures (ECACC)
(Date:12/14/2009)... In support of the United Nations Framework Convention ... European Environment Agency hosted the ,Bend the Trend, ... climate networking platform and premiere the screening of ... ,Environmental Atlas of Europe, a joint project of ... Programme (UNEP) and ESA, is a series of ...
(Date:12/13/2009)... have identified plant enzymes that may help to engineer ... use water more efficiently. The finding could help to ... , Plants take in the carbon dioxide they need ... of leaves. But for each molecule of the gas ... same openings. The pores can tighten to save water ...
(Date:12/13/2009)... Scientists have discovered five genetic variants that are associated ... by an international consortium of 96 scientists from 63 ... the molecular basis of lung diseases. , The new ... like Chronic Obstructive Pulmonary Disease (COPD) and asthma. In ... treatments because the molecular pathways that affect the health ...
Breaking Biology News(10 mins):'Environmental Atlas of Europe' unveiled at COP15 2Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops 2Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops 3New genes for lung disease discovered 2Cancer Survivors Share The Day I Found Out 28TM 29 58807 1Cancer Survivors Share The Day I Found Out 28TM 29 58807 2CORRECTION 3A Celebrate Your Family 58803 1CORRECTION 3A Celebrate Your Family 58803 2CORRECTION 3A Celebrate Your Family 58803 3CORRECTION 3A Celebrate Your Family 58803 4University Hospitals Case Medical Center earns prestigious national award for excellence 58801 1University Hospitals Case Medical Center earns prestigious national award for excellence 58801 2
... the Department of Energy,s Oak Ridge National Laboratory and ... developing nerve cells may hold a key to predicting ... disease. , St. Jude scientists have linked movement and ... and retinas of young mice to certain diseases. Now, ...
... discovered that cane toads are far more susceptible to being ... research published in the British Ecological Society,s journal ... toad,s armour that could help control the spread of this ... and his colleagues Georgia Ward-Fear, Matt Greenlees and Greg Brown ...
... new, environmentally friendly coating that protects metals against ... team of researchers from Sheffield Hallam University. At ... today, (Monday 30 March), Jeanette Gittens and colleagues ... bacterium into a sol-gel coating which then protected ...
Other Biology News:ORNL, St. Jude track neurons to predict and prevent disease 2Aussie meat ants may be invasive cane toad's Achilles' heel 2
(Date:12/14/2009)... -- Decision Resources, one of the world,s leading ... issues, finds that, owing to the launches of ... will increase more than sevenfold from $790 million ... the United States, France, Germany, Italy, Spain, the ... report entitled Atrial Fibrillation finds that ...
(Date:12/11/2009)... Dendreon Corporation (Nasdaq: DNDN ) announced today ... offering have exercised in full their option to ... at the public offering price of $24.75 per ... the size of the offering to an aggregate ... expects to receive net proceeds from the offering ...
(Date:12/11/2009)... Ambit Biosciences Corporation announced today the enrollment and dosing ... Center of the first patient in the ACE ( ... fficacy) Phase 2 pivotal trial in patients with relapsed ... a novel, orally available, potent and highly selective small ... kinase-3 (FLT3) inhibitor. The ACE study is designed ...
(Date:12/11/2009)... Biotech Inc. (TSX:ONC, NASDAQ: ONCY ) ("Oncolytics" or ... Alan Warrander to the role of Senior Vice ... Warrander will be responsible for the execution of ... Brad Thompson, President and CEO of Oncolytics. "Having ... Phase 3 trial examining REOLYSIN in combination with ...
Breaking Biology Technology:The Atrial Fibrillation Drug Market Will Increase More Than Sevenfold, from $790 Million in 2008 to $6.1 Billion in 2018 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 3Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 2Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 3Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 4Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 5Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 2Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 3